These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25075864)

  • 21. Differential long-term effects of insulin-like growth factor-I (IGF-I) growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats.
    Fielder PJ; Mortensen DL; Mallet P; Carlsson B; Baxter RC; Clark RG
    Endocrinology; 1996 May; 137(5):1913-20. PubMed ID: 8612531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human insulin-like growth factor-I treatment inhibits gluconeogenesis in a transgenic mouse model of type 2 diabetes mellitus.
    Pennisi P; Gavrilova O; Setser-Portas J; Jou W; Santopietro S; Clemmons D; Yakar S; LeRoith D
    Endocrinology; 2006 Jun; 147(6):2619-30. PubMed ID: 16513827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effects of insulin-like growth factor-I and human chorionic gonadotropin in the rat ovary.
    Damario MA; Bogovich K; Liu HC; Rosenwaks Z; Poretsky L
    Metabolism; 2000 Mar; 49(3):314-20. PubMed ID: 10726907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.
    Camacho-Hübner C; Woods KA; Miraki-Moud F; Hindmarsh PC; Clark AJ; Hansson Y; Johnston A; Baxter RC; Savage MO
    J Clin Endocrinol Metab; 1999 May; 84(5):1611-6. PubMed ID: 10323388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
    Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
    Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of infusion of insulinlike growth factor (IGF) I, IGF-II, and insulin on glucose and protein metabolism in fasted lambs.
    Douglas RG; Gluckman PD; Ball K; Breier B; Shaw JH
    J Clin Invest; 1991 Aug; 88(2):614-22. PubMed ID: 1864971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
    Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
    Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of recombinant human IGF-I on protein metabolism in post-operative patients without nutrition compared to effects in experimental animals.
    Sandström R; Svanberg E; Hyltander A; Haglind E; Ohlsson C; Zachrisson H; Berglund B; Lindholm E; Brevinge H; Lundholm K
    Eur J Clin Invest; 1995 Oct; 25(10):784-92. PubMed ID: 8557066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. rhIGF-I administration in humans: differential metabolic effects of bolus vs. continuous subcutaneous delivery.
    Mauras N; Martha PM; Quarmby V; Haymond MW
    Am J Physiol; 1997 Apr; 272(4 Pt 1):E628-33. PubMed ID: 9142884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between the regulation of recombinant human IGF-2 on eye growth and form-deprivation in guinea pig.
    Deng ZH; Tan J; Liu SZ; Zhao SZ; Wang JT
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):519-25. PubMed ID: 20135141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-I binding proteins, IGF-I binding protein mRNA and IGF-I receptor mRNA in rats with acute renal failure given IGF-I.
    Bohé J; Ding H; Qing DP; Yoon K; Hirschberg R; Wolfgang GH; Kopple JD
    Kidney Int; 1998 Oct; 54(4):1070-82. PubMed ID: 9767523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex reversal and aromatase in chicken.
    Vaillant S; Dorizzi M; Pieau C; Richard-Mercier N
    J Exp Zool; 2001 Dec; 290(7):727-40. PubMed ID: 11748621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of in ovo injection of chrysin, quercetin and ascorbic acid on hatchability, somatic attributes, hepatic oxidative status and early post-hatch performance of broiler chicks.
    Khaligh F; Hassanabadi A; Nassiri-Moghaddam H; Golian A; Kalidari GA
    J Anim Physiol Anim Nutr (Berl); 2018 Feb; 102(1):e413-e420. PubMed ID: 28636279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of insulin-like growth factor binding protein-2 as a biochemical surrogate marker for the in vivo effects of recombinant human insulin-like growth factor-1 in mice.
    Bhat RV; Engber TM; Zhu Y; Miller MS; Contreras PC
    J Pharmacol Exp Ther; 1997 Apr; 281(1):522-30. PubMed ID: 9103540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats.
    Guler HP; Zapf J; Scheiwiller E; Froesch ER
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4889-93. PubMed ID: 3387445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.